Ledger.Open graph →
SEC Form D · Amendment · filed March 23, 2016

Renibus Therapeutics, Inc

Offering
$12.5M
Sold
$8.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LANTANA, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jocelyn D. Keyser · Lantana, TXDirectorDale Jones · Lantana, TXDirectorHarpreet Kaur · Lantana, TXExec · DirectorNels D. Bergmark · Lantana, TXExecJennifer D. Rasmussen · Lantana, TXDirectorCarlos Guillem · Lantana, TXExec · DirectorAlexander Bullington · Forest Hill, MDDirectorTimothy L. Hoel · Troy, MIDirectorGregory Dinardo · Austin, TXExecLarry L. Adloff · Troy, MIExec · DirectorJason L. Yoffy · Troy, MIExec · DirectorArthur B. Mcwood · Troy, MIDirectorJohn B. Coppolino · Troy, MIExecLawrence B. Carlson · Troy, MIDirectorDaniel J. Jenuwine · Troy, MIExec · DirectorJim M. Hodge · Henderson, NVExec · DirectorRandon M. Hansen · Henderson, NVDirectorMark M. Stoker · Henderson, NVDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗